Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Davidzon

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2020
Human biodistribution and radiation dosimetry of [<sup>18</sup>F]DASA-23, a PET probe targeting pyruvate kinase M2Corinne Beinat, Chirag B Patel, Tom Haywood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021
Prognostic Value of Bone Marrow Metabolism on Pretreatment <sup>18</sup>F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 TherapyRyusuke Nakamoto, Lisa C Zaba, Tie Liang, et al.
Molecular Imaging and Biology|January 20, 2021
The Clinical Utility of <sup>18</sup>F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA ApprovalRyusuke Nakamoto, Caitlyn Harrison, Hong Song, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2020
Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learningKevin T Chen, Matti Schürer, Jiahong Ouyang, et al.
Cancer Research|June 20, 2012
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancerViswam S Nair, Olivier Gevaert, Guido Davidzon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2021
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate CancerLucia Baratto, Hong Song, Heying Duan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2020
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapyRyusuke Nakamoto, Lisa C Zaba, Jarrett Rosenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2023
Early-Frame [<sup>18</sup>F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [<sup>15</sup>O]Water Gold StandardAtes Fettahoglu, Moss Zhao, Mehdi Khalighi, et al.
Neuromuscular Disorders : NMD|May 18, 2010
Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 geneHasan O Akman, Guido Davidzon, Kurenai Tanji, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2021
True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretationKevin T Chen, Tyler N Toueg, Mary Ellen Irene Koran, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2020
Human biodistribution and radiation dosimetry of [<sup>18</sup>F]DASA-23, a PET probe targeting pyruvate kinase M2Corinne Beinat, Chirag B Patel, Tom Haywood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2021
Prognostic Value of Bone Marrow Metabolism on Pretreatment <sup>18</sup>F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 TherapyRyusuke Nakamoto, Lisa C Zaba, Tie Liang, et al.
Molecular Imaging and Biology|January 20, 2021
The Clinical Utility of <sup>18</sup>F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA ApprovalRyusuke Nakamoto, Caitlyn Harrison, Hong Song, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2020
Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learningKevin T Chen, Matti Schürer, Jiahong Ouyang, et al.
Cancer Research|June 20, 2012
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancerViswam S Nair, Olivier Gevaert, Guido Davidzon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2021
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate CancerLucia Baratto, Hong Song, Heying Duan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2020
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapyRyusuke Nakamoto, Lisa C Zaba, Jarrett Rosenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2023
Early-Frame [<sup>18</sup>F]Florbetaben PET/MRI for Cerebral Blood Flow Quantification in Patients with Cognitive Impairment: Comparison to an [<sup>15</sup>O]Water Gold StandardAtes Fettahoglu, Moss Zhao, Mehdi Khalighi, et al.
Neuromuscular Disorders : NMD|May 18, 2010
Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 geneHasan O Akman, Guido Davidzon, Kurenai Tanji, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2021
True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretationKevin T Chen, Tyler N Toueg, Mary Ellen Irene Koran, et al.
Pageof 5